KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) EBIT Margin (2018 - 2025)

Historic EBIT Margin for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to 10.95%.

  • Adaptive Biotechnologies' EBIT Margin rose 812200.0% to 10.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.93%, marking a year-over-year increase of 817600.0%. This contributed to the annual value of 90.83% for FY2024, which is 425000.0% up from last year.
  • Adaptive Biotechnologies' EBIT Margin amounted to 10.95% in Q3 2025, which was up 812200.0% from 42.52% recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' EBIT Margin peaked at 10.95% during Q3 2025, and registered a low of 621.01% during Q2 2023.
  • In the last 5 years, Adaptive Biotechnologies' EBIT Margin had a median value of 116.45% in 2024 and averaged 132.07%.
  • Per our database at Business Quant, Adaptive Biotechnologies' EBIT Margin plummeted by -5007600bps in 2023 and then skyrocketed by 5114600bps in 2024.
  • Over the past 5 years, Adaptive Biotechnologies' EBIT Margin (Quarter) stood at 162.39% in 2021, then skyrocketed by 56bps to 70.99% in 2022, then plummeted by -119bps to 155.22% in 2023, then soared by 54bps to 71.3% in 2024, then skyrocketed by 115bps to 10.95% in 2025.
  • Its last three reported values are 10.95% in Q3 2025, 42.52% for Q2 2025, and 56.45% during Q1 2025.